Over the next few weeks, while browsing cuties on the dating app, Tinder, you may find an image of a celebrity with an ‘organ donor’ icon next to their photo. By swiping right (usually an action which means “sexy!”), you will be given the option to register as an organ donor.
In what might seem an unlikely partnership, Tinder has partnered with the UK’s National Health Service (NHS) to recruit organ donors.
Why? Desperate times sometimes call for unconventional measures.
Samsung’s already wide product family is getting even bigger thanks to its new chip dubbed the “Samsung Bio-Processor.” As the company tells it, it’s already in mass production and is “specifically designed to allow accelerated development of innovative wearable products for consumers who are increasingly monitoring their health and fitness on a daily basis.” Phew. The announcement post goes on to say that the processor is the first all-in-one health solution chip and that since it’s packing a number of different control and sensor units (like a quintet of Analog Front Ends, a microcontroller unit, digital signal processor and eFlash memory) it can do all these tricks without the need for external processing.
The idea behind the silicon is to be the one-stop wearable fitness resource. Those five AFEs? One keeps track of bioelectrical impedance analysis, while the others focus on volumetric measurements of organs, an electrocardiogram and skin temperature, among other things. Bear in mind that Samsung’s latest smartwatch, the Gear S2, only tracks your heart rate. Same goes for the Apple Watch. Considering how err… interesting Samsung wearables tend to be, a possible scenario here is that the tech giant won’t keep the Bio-Processor all to itself. Nope, the real money here lies in potentially licensing it out to other folks, as it’s wont to do with its other self-made parts.
We won’t have to wait too long to see these in the wild, either: Samsung promises it’ll be packed into devices available early next year. If you’re wondering where, the inevitable follow-up to the aforementioned Gear S2 successor is a pretty likely bet. Whether that shows its face at CES or Mobile World Congress is the real question, though.
BY: DANIEL KORN
The very mention of “nanobots” can bring up a certain future paranoia in people—undetectable robots under my skin? Thanks, but no thanks. Professor Ido Bachelet of Israel’s Bar-Ilan University confirms that while tiny robots being injected into a human body to fight disease might sound like science fiction, it is in fact very real.
Cancer treatment as we know it is problematic because it targets a large area. Chemo and radiation therapies are like setting off a bomb—they destroy cancerous cells, but in the process also damage the healthy ones surrounding it. This is why these therapies are sometimes as harmful as the cancer itself. Thus, the dilemma with curing cancer is not in finding treatments that can wipe out the cancerous cells, but ones that can do so without creating a bevy of additional medical issues. As Bachelet himself notes in a TEDMED talk: “searching for a safer cancer drug is basically like searching for a gun that kills only bad people.”
Death is a disease.
Diseases can and will be cured.
Do the math. wink
Disease GWAS show substantial genetic overlap with longevity. Shown are results for coronary artery disease and Alzheimer’s disease. The y axis is the observed P values for longevity, and the x axis is the expected P values under the null hypothesis that the disease is independent of longevity. The cyan, blue and purple lines show the P values for longevity of the top 100, 250, and 500 disease SNPs from independent genetic loci, respectively. Red lines show the background distribution of longevity P values for all independent genetic loci tested in both the longevity and disease GWAS. The grey horizontal line corresponds to the threshold for nominal significance (P = 0.05) for longevity. Significance of enrichment was determined with the hypergeometric test. (credit: Kristen Fortney et al./PLOS Genetics)
What’s the secret of centenarians who have health and diet habits similar to the average person but have remained active and alert at very old ages?
Genes. That’s according to scientists at Stanford University and the University of Bologna, who have written a new report published in PLOS Genetics, based on their finding of several disease variants that may be absent in centenarians compared to the general population.
CAMBRIDGE, Mass. (AP) – X-ray vision, a comic book fantasy for decades, is becoming a reality in a lab at MIT.
A group of researchers led by Massachusetts Institute of Technology professor Dina Katabi has developed software that uses variations in radio signals to recognize human silhouettes through walls and track their movements.
Researchers say the technology will be able to help health care providers and families keep closer tabs on toddlers and the elderly, and it could be a new strategic tool for law enforcement and the military.
Society isn’t ready to take a medium seriously until it can provide certain things. The first, and most obvious, achievement is it must work with porn. Virtual reality passed that benchmark a long time ago, and it seems to have no problem revisiting it over and over again. So what’s the next trial that virtual reality must face on its quest to becoming a true consumer medium?
Someone has to try and make me exercise with it.
That someone are the makers of the Virzoom, an exercise bike and app suite for the Oculus Rift headset. The VirZOOM is available for preorder today, with the first 300 units are $200 (it’s regular price $250).
Healthy living isn’t meaningless, but while all of us can make positive lifestyle modifications, genes play a massive role in longevity — or there would be no species variation. We’re still discovering exactly which genes provide a longevity boost and what they do, but we now know 7 variants could help give you an advantage.
The search for a longevity gene
Previous efforts to search out a ‘longevity gene’ have been largely unsuccessful, so researchers led by Stuart Kim at Stanford decided to focus on ‘bad’ gene variants this time — or more crucially a lack of them. They analysed 800 people over 100 and 5000 people over 90 and found that while many variants are common in the average person, possession of fewer ‘bad’ versions of 5 crucial genes was indeed associated with longevity. Many long-lived individuals are able to avoid chronic disease despite harmful lifestyle choices like smoking, and this could be one of the explanations. These confirmed 5 add to 2 already associated with longer lifespans.
Robots and artificial intelligence (AI) will dominate legal practice within 15 years, perhaps leading to the “structural collapse” of law firms, a report predicting the shape of the legal market has envisaged.
Civilisation 2030: The near future for law firms, by Jomati Consultants, foresees a world in which population growth is actually slowing, with “peak humanity” occurring as early as 2055, and ageing populations bringing a growth in demand for legal work on issues affecting older people.
This could mean more advice needed by healthcare and specialist construction companies on the building and financing of hospitals, and on pension investment businesses, as well as financial and regulatory work around the demographic changes to come; more age-related litigation, IP battles between pharmaceutical companies, and around so-called “geriatric-tech” related IP.
